Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Laurus Labs Limited
LAURUSLABS | NSE
1,096.10
INR-18.25
-1.64%
LAURUSLABS | NSE
Loading StockChartView...
About Laurus Labs Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
22/04/2026
Close
1,096.10
Open
1,110.00
High
1,119.90
Low
1,094.00
Laurus Labs Limited together with its subsidiaries engages in the development manufacture and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops manufactures and sells APIs and advanced intermediates for anti-retroviral (ARV) antidiabetic cardiovascular proton pump inhibitors (PPIs) oncology gastroenterology and hepatitis C therapeutic areas. It also develops and manufactures oral solid formulations for ARVs anti-diabetic cardiovascular PPIs and central nervous system. In addition the company provides contract development and manufacturing services for pharmaceutical companies; and manufactures and sells specialty ingredients used in the nutraceutical dietary supplements and cosmeceutical products. Further it develops novel enzymatic solutions for industrial biotechnology and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceutical field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad India.
View LessLAURUSLABS | NSE
Risk
31.6
Sharpe
2.65
Luna's Score
54/100
Recommendation
Hold
Luna says (LAURUSLABS | NSE)
What's Working
Low 6-Month Volatility (<30%)
Strong Sharpe Ratio (> 1.2)
What's not Working
Weakness based on declining price with high volume
Price Below SMA10D
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
24.0%1 month
31.6%3 months
35.5%6 months
29.6%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
172.16
Fwd. PE
-
Price to book
6.30
Debt to equity
0.63
Debt to assets
0.31
Ent. to EBITDA
35.59
Ent. to rev.
5.65
PEG
-
Other Fundamentals
EBITDA
7.65B
MarketCap
590.97B
MarketCap(USD)
6.30B
Div. yield
0.17
Op. margin
5.66
Erngs. growth
-50.00
Rev. growth
1.10
Ret. on equity
3.98
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
72.75
Range1M
187.45
Range3M
226.90
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.03
Price X volume
2.10B
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 35.59 | 24.85 | Expensive |
| Ent. to Revenue | 5.65 | 11.40 | Cheaper |
| PE Ratio | 172.16 | 51.36 | Expensive |
| Price to Book | 6.30 | 6.83 | Par |
| Dividend Yield | 0.17 | 0.52 | Poor |
| Std. Deviation (3M) | 35.54 | 42.17 | Par |
| Debt to Equity | 0.63 | 0.35 | Expensive |
| Debt to Assets | 0.31 | 0.17 | Expensive |
| Market Cap | 590.97B | 290.82B | Market Leader |
